| Investigator |
Institution |
Keywords |
| |
|
|
| Moufida ACHOUR
| university of sciences and technology of Oran(USTO) |
mimouna2004 |
| Antonella Agrusti
| Universit? |
brain |
| Alex Agyemang
| Barts and the London School of Medicine and Dentistry |
Acetylcholinesterase inhibitors, Alzheimer's disease, Dementia, PK/PD |
| Paul Aisen
| Georgetown University |
baseline data |
| Paul Aisen
| UCSD |
volumetric analysis |
| Howard Aizenstein
| University of Pittsburgh |
tensor-based morphometry, atlas-based segmentation, classifier algorithms |
| Roman Alberca
| HU Virgen del Roc? |
Alberca |
| Gene Alexander
| Arizona State University |
Voxel-based Morphometry, SPM, Brain Mapping |
| Jeffry Alger
| David Geffen School of Medicine at UCLA |
stroke, brain atlas, template |
| Fabio Almeida
| University of Arizona Medical Center |
optimizing methods PET quantitation |
| shyam anand
| Indian Institute of Technology guwahati |
fMRI analysis |
| Rishi Anand
| ABV-IIITM |
neural network , MRI |
| (Michael) Colin Ard
| University of California, San Diego |
cerebrospinal fluid |
| Tom Armor
| Certus International |
normal database |
| Steven Arnold
| University of Pennsylvania |
tau, amyloid, age, ethnicity |
| H. Michael Arrighi
| Elan Pharmaceuticals |
progression |
| Florent Aubry
| INSERM (French Institute of Health and medical Research) |
brain morphology, longitudinal studies, neurodegenrative study |
| Brian Avants
| Univ. of Pennsylvania |
diffeomorphisms, longitudinal neurodegeneration |
| Gopal Avinash
| GE Healthcare |
ADNI MRI FMRI PET |
| Sukrati Awasthi
| IIITA |
MRI,PET |
| MOSUN AYAN-OSHODI
| Walden University |
genetic components of Alzheimer's disease |
| Ulas Bagci
| the university of nottingham |
signal processing, image processing, medical image processing |
| John Baker
| State University of New York at Buffalo |
regression analysis, functional assessment, neuroimaging, neuropsychology |
| Jerome Barakos
| California Pacific Medical Center |
amyloid angiopathy |
| Jonathan Bard
| Wyeth Research |
Alzheimer's Disease, Analysis, MRI |
| Steven Barrett
| GlaxoSmithKline |
Data Analysis Methodology |
| George Bartzokis
| UCLA |
structure, intensity, diagnosis |
| Corinna Bauer
| Boston University School of Medicine |
T2 algorithms, MRI manufacturer |
| Richard Baumgartner
| Merck Research Laboratories |
image processing, feaure extraction |
| Laurel Beckett
| UC Davis |
Biostatistics |
| laurent bedat
| INSA rennes |
lossless image compression |
| Barry Bedell
| McGill University |
MRI, PET |
| Barry Bedell
| Montreal Neurological Institute |
MRI PET analysis |
| Martin Bednar
| Pfizer Inc |
alzheimer's |
| Duane Beekly
| University of Washington |
NACC |
| Stephan Bek
| Novartis |
Biomarker |
| Boubakeur Belaroussi
| Bio-Imaging Technologies S.A.S. |
Atrophy Measurement Brain Hippocampus Validation Deformable Registration |
| Anissa Ben Salem
| EMF Consulting |
Statistics Analysis Modelling Epidemiology |
| Zvi Bentwich
| Ben Gurion University Faculty of Health Sciences |
Neuroimaging;Stages; Progression;Prognostic markers |
| Jay Bergeron
| Pfizer |
Pfizer Clinical Technologies Informatics |
| Charles Bernick
| University of Nevada |
depression, hypertension, diabetes |
| Francois Bernier
| Eisai |
biomarker, proteomics, transcriptomics, metabolomics |
| Lars Bertram
| Max-Planck Institute for Molecular Genetics |
genetic association studies; meta-analysis; AlzGene |
| Alessandro Biffi
| Massachusetts General Hospital |
GWAS, Alzheimer disease, APOE |
| Don Bigler
| Penn State Hershey Medical Center |
Support Vector Machine (SVM), Classifier |
| Bill Billing
| Pfizer Inc |
Pfizer Clinical Trials |
| Courtney Birch
| University of Oxford |
Segmentation, Statistical analysis |
| Ronald Black
| Wyeth Research |
Wyeth clinical research |
| Thomas Blaettler
| Bristol-Myers Squibb company |
BMS representative to ADNI |
| Leo Bleicher
| NA |
segmentation, software |
| Clara Bodelon
| University of Washington |
Fluid biomarkers, early stages |
| Arun Bokde
| Trinity College Dublin |
MRI, grey matter, volumetric, hippocampus |
| Alan Bond
| Institute of Neuroscience, UCLA Medical Center, |
cognitive deficit, system-level, brain model |
| Aaron Bonner-Jackson
| Brown Medical School, Rhode Island Hospital |
Cognitive reserve, functional decline, brain volume, neuropsychology |
| Madhu Boppana
| NYU |
research |
| Lauren Boreta
| Northern California Institute for Research and Education (NCIRE) |
Alzheimer's Disease |
| Michael Borrie
| University of Western Ontario |
Ventricular volume, atrophy, AD, MCI |
| Pierrick Bourgeat
| CSIRO ICT Centre |
Segmentation, registration, longitudinal study |
| Richard Boyes
| Institute of Neurology |
Boundary Shift Integral |
| Elimor Brand-Schieber
| Eisai Medical Research |
Biomarkers, progression, severity |
| James Brewer
| University of California, San Diego |
Medial Temporal Lobe, Hippocampus, PET, Morphometry, Volumetrics |
| Adam Brickman
| College of Physicians and Surgeons, Columbia University |
white matter hyperintensities, PIB, amyloid |
| David Brooks
| Imperial College London |
PIB PET MCI |
| Patrick J. Brown
| College of Physicians and Surgeons, Columbia University |
functional impairment, neuropsychological, neuroimaging, Alzheimer's disease |
| Jeffrey Browndyke
| Duke University Medical Center |
morphometry precuneus inferior parietal lobule MCI normals |
| Vanessa Bruat
| Genizon Biosciences |
Biomarkers |
| Simon Brunton
| King's College London |
Voxel Based Morphometry, SPM |
| Ralph Buchert
| University Medical Center Hamburg-Eppendorf |
computer aided diagnosis; FDG-PET; MRI |
| Chris Buckley
| GE Healthcare |
MRI, ventricals |
| Joshua Bueller
| UCLA |
muti-site imaging, interface |
| Chloe Bui
| Perceptive Informatics |
tools for image analysis. |
| Cyrill Burger
| PMOD Technologies |
Alzheimer's discrimination, PALZ, pattern analysis |
| Jeffrey Burns
| University of Kansas School of Medicine |
body mass index, diabetes, hippocampal atrophy, whole brain atrophy |
| David Burton
| Alzheimer's Disease Education and Referral Center, the National Insitute on Agin |
n/a |
| Nigel Cairns
| Washington University |
neuropathology |
| Andrea Calabria
| CNR |
Record Linkage, Data Fusion, Data Mining on Brain Diseases |
| PIERO CALVINI
| UNIVERSITA' DI GENOVA |
segmentation of hippocampus, morphometry, Alzheimer's disease early diagnosis |
| Aaron Campbell
| UC Davis |
UC Davis, Public Health Sciences |
| Stefan Cano
| Institute of Neurology |
Psychometrics, Rasch analysis |
| Aristides Capizzano
| University of Iowa Hospitals & Clinics |
longitudinal MRI, neurodegeneration, phylogeny |
| Zografos Caramanos
| Montreal Neurological Institute / McGill University |
brain volume, ventricular volume, cortical-grey-matter thickness |
| Adam Carle
| University of North Florida |
Item response theory |
| Christopher Carlson
| Eli Lilly and Company |
immunization |
| Jeremy Carmasin
| Massachusetts General Hospital |
PIB FDG AD MCI |
| David Cash
| IXICO Ltd |
huntingtons hdni MR imaging sequence optimization |
| Jesse Cedarbaum
| Elan Pharmaceuticals, Inc |
MCI, biomarker |
| Pierre Celsis
| INSERM |
Cortical thickness, quantitation of brain atrophy |
| Shu-Kai Chang
| University of Pennsylvania |
machine learnning |
| Neda Changizi
| Simon Fraser University |
Corpus Callosum |
| pascal chanu
| Pharsight |
modeling biomarker imaging |
| Linda Chao
| UCSF |
PIB, MCI, cognition |
| Ting Chen
| University of Florida |
segmentation |
| Kewei Chen
| Banner Alzheimer Institute |
PET SPM image-derived input function, |
| Wei Chen
| National Research Council |
validate; stuctrual changes |
| Howard Chertkow
| Lady Davis Institute for Medical Research |
cortical thickness VBM MCI BA39 BA40 |
| Gloria Chiang
| UCSF |
DTI |
| Jane Chisholm
| Pfizer Inc |
cholesterol, amyloid, burden |
| Tarun Chitra
| AstraZeneca Pharmaceuticals |
cognition, MR, poset |
| Youngsang Cho
| KAIST |
Surface-based analysis, hippocampus |
| John Choe
| Transition Therapeutics |
ADAS-cog, mild Alzheimer's disease, MCI |
| James Choi
| Sabio Academy |
Image processing, Pattern Recognition |
| YIYU CHOU
| UCLA |
AD Ventricle |
| Suresh Choubey
| GE Healthcare |
machine learning, pattern recognition |
| Anette Luther Christensen
| Aalborg University |
atrophy, cerebellum |
| Chris Clark
| University of Pennsylvania |
MCI, AD, Controls, MRI PET |
| David Clark
| University of Alabama at Birmingham |
hippocampus, CASL, functional imaging |
| David Clayton
| Genentech |
image processing, Alzheimer's disease, MRI |
| Karen-Louise Clemmesen
| Aalborg University |
Alzheimer's, MRI, PET |
| David Clunie
| PixelMed Publishing and RadPharm, Inc |
DICOM compression |
| Alexandre Coimbra
| Merck Research Laboratories |
MRI, automated-segmentation |
| Patricia Cole
| Eisai Medical Research |
trial sample size, imaging, biomarkers |
| Louis Collins
| Montreal Neurological Institute |
AD, hippocampus, atrophy, segmentation, MRI |
| Olivier Colliot
| Universit? Pierre et Marie Curie - Paris 6 |
classification hippocampus SVM AD MCI |
| Janelle Cooper
| University of Wisconsin - Madison |
T2 hypointensity, globus pallidus, NBIA |
| Paul Coplan
| School of Medicine, University of Pennsylvania |
biomarker, progression |
| Paul Crane
| University of Washington |
AMNART, literacy, age, education, gender |
| Gerald Crans
| Elan Pharmaceuticals |
cognitive tests |
| Dana Crawford
| Albany Medical College |
Alzheimer's genes, risk genes, diet |
| Robert Croop
| Bristol-Myers Squibb |
biomarkers |
| Daniel Crowther
| Wyeth |
Training account |
| William Crum
| Institute of Psychiatry / Kings College London |
image registration, morphometry, atrophy |
| Valerie Cullen
| Link Medicine Corp |
CSF biomarkers |
| Ingo Curdt
| Abbott Diagnostics |
AD, A?, Tau |
| Charles Curry
| Numenta, Inc. |
statistical learning classification |
| Steven Curtis
| University of Washington |
Item Response Theory, Bifactor Models, Model Selection |
| Giovanni d'Avossa
| Bangor University |
cerebellum, atrophy |
| Lori Daiello
| Brown University/Rhode Island Hospital |
Alzheimer's Disease; medication; cerebral atrophy |
| VITO DOMENICO DAMATO
| AZIENDA OSPEDALIERO-UNIVERSITARIA "OSPEDALI RIUNITI" |
dmtvdm |
| Eveleen Darby
| Baylor College of Medicine |
Alzheimer Disease |
| Christos Davatzikos
| University of Pennsylvania |
classification, MCI, conversion to AD |
| Julie Davidson
| GlaxoSmithKline R&D |
decline, progression, risk factor |
| Geert De Meyer
| INNOGENETICS |
biomarker |
| Giorgio De Nunzio
| University of Salento |
si118ma353 |
| Charles DeCarli
| University of California at Davis |
MRI, cerebrovascular disease |
| Bryan Dechairo
| Pfizer Global Research and Development |
MCI, Genomics, Biomarkers, Imaging |
| Kristina DeDuck
| Perceptive Informatics, Inc |
Image Analysis Tools |
| Manuel Delfino
| Institut de Fisica d'Altes Energies |
postprocessing |
| Ebrahim Delpassand
| Excel Diagnostic Imaging Clinics |
Teaching, Alheimer's dementia, MCI |
| Douglas Denney
| University of Kansas |
factor analysis, cognition, brain imaging |
| Delphine D?py Carron
| Calliopae MSC |
cognition cognitive decline |
| Rahul Desikan
| Martinos Center for Biomedical Imaging |
MCI, MRI, morphometry |
| Viswanath Devanarayan
| Abbott Labs |
biomarkers, disease prognosis, disease progression, multivariate analysis |
| Gloria Diaz
| Universidad Nacional de Colombia |
MRI studies classification, Feature relevance, Feature Selection |
| Ramon Diaz-Arrastia
| University of Texas Southwestern Medical Center |
homocysteine; inflammatory biomarkers; congnitive deficits |
| Bradford Dickerson
| Massachusetts General Hospital |
MRI, PET, cortical thickness, MCI, AD |
| David Dinishak
| Stanford University |
neuropsychology |
| Ivo Dinov
| UCLA |
Alzheimer's disease, statistics, shape |
| Belma Dogdas
| Merck and Co Inc |
image registration, image segmentation, AD |
| Donald Doherty
| Brainstage, Inc. |
biomarkers patients MCI Alzheimer's disease |
| Michael Donohue
| UC San Diego |
ADCS |
| Judy Doolittle
| Radiant Research |
Alzheimer's Disease |
| patrice douillet
| sanofi-aventis |
MRI, duration of disease |
| Shuyan Du
| Bristol-Myers Squibb |
MRI, PET, CSF |
| Simon Duchesne
| Universit? Laval |
Morphometry, MRI, multidimensional analysis |
| Kevin Duff
| University of Iowa |
practice effects, repeated cognitive testing |
| Jürgen Dukart
| Max Planck Institute for Human Cognitive and Brain Sciences |
MRI FDG-PET dementia multivariate evaluation |
| Kevin Dykstra
| Pharsight Corporation |
Math Modeling, Drug and Disease Modeling, Clinical Trial Simulation |
| Nancy Earl
| GlaxoSmithKline |
decline treatment |
| Paul Edison
| Imperial College London |
PIB, FDG, amyloid, A beta, ApoE |
| GOUTHAM EDULA
| ASTRAZENECA R&D |
Image analysis, MRI |
| Richard Einstein
| ExonHit Therapeutics, Inc |
Biomarkers, blood-based test, gene expression, GWAS, brain imaging |
| Andrew Eisen
| Eisai Medical research |
biomarker |
| Ahmet Ekin
| Philips Research |
MR-based markers, longitudinal study |
| GAL ELIDAN
| Stanford University |
VISION, MACHINE LEARNING, AUTOMATIC OUTLINING |
| Valur Emilsson
| Merck & Co. |
genetics, brain networks, eSNPs, cognition |
| Deniz Erten-Lyons
| Oregon Health & Science University |
Genetics, Healthy Brain Aging |
| Simon Eskildsen
| Aalborg University |
cortical thickness, brain mapping, segmentation |
| Michael Ewers
| Trinity College Dublin |
PIB-PET, FDG-PET |
| Michael Farnum
| J&J PRD |
biomarkers pharmaceuticals |
| Lindsay Farrer
| Boston University School of Medecine |
gwas alzheimers meta-analysis adgc |
| Ali Farzan
| University Putra Malaysia |
GA Fuzzy Classifier, SVM, NeuroFuzzy |
| Marco Favetta
| INFN |
MRI, Alzheimer, Hippocampus |
| Howard Feldman
| University of British Columbia |
MRI, brain extraction tools, whole brain volume |
| yuanyuan feng
| China Academy of Science |
fmri |
| Yan Feng
| Bristol Myers Squibb Co. |
biomarker identification, Prodromal, Pre-Symptomatic AD |
| Dai Feng
| Merck & Co., Inc. |
exploration |
| Christine Fennema-Notestine
| UCSD |
MRI, thickness, morphometry, shape analysis, PET |
| Michel Fernandes
| FEI University |
Alzheimer Disease Cognitive Impairment Pattern |
| Luca Ferrarini
| Leiden University Medical Center |
AD, MCI, shape-based markers, hippocampi, ventricles |
| Luiz Ferreira
| Institute of Psychiatry, Faculty of Medicine, University of Sao Paulo |
Alzheimer´s disease; systematic review; neuroimaging |
| Fernando Figueira
| Hospital da Penitencia |
Alzheimer disease, prevalence, epidemiology |
| Michal Figurski
| University of Pennsylvannia |
UPenn, Leslie Shaw |
| Anders Fjell
| University of Oslo |
mrophometry, neuropsychology, PET, biomarkers |
| Derek Flenniken
| UCSF & VA Medical Center, San Francisco |
CIND |
| P. Thomas Fletcher
| University of Utah |
MRI, PET |
| Mark Forman
| Merck and Co. |
tau, Abeta, CSF, proteomics |
| Alan Forsythe
| UCLA |
Partition trees, time to event, modified Gehan weights, validation |
| Sabrina Fox-Bosetti
| Merck |
hippocampus |
| Alexander L. Francis
| Purdue University |
Behavioral testing, cognitive training, normal aging, speech perception |
| Conrado Franco-Villalobos
| ITESM |
Image Analysis Evolution |
| Stefanie Freeman
| Abbott Laboratories |
clinical trials, neuropathology |
| Christoph M. Friedrich
| Fraunhofer Institute SCAI |
detection of complex interaction patterns |
| Michel Friesenhahn
| Genentech |
ADAS-Cog longitudinal data models |
| Lars Frings
| University of Freiburg, Germany |
gray matter atrophy, cognition, naming, voxel-based morphometry |
| Giovanni Frisoni
| IRCCS San Giovanni di Dio FBF - The National Center for Research and Care of Alz |
ADNI EADNI |
| Klaus Fritzsche
| German Cancer Research Center |
validation, evaluation, atrophy estimation, voxel based morphometry |
| Joanna Fueyo
| IBM |
Pattern recognition, text mining, algorithms |
| Yoko Fujimoto
| Pfizer Japan R&D |
Clinical Reserch |
| ken fujiwara
| NCGG |
nilsgo |
| Terence Fullerton
| Pfizer Global Research and Development |
cognition, clinical endpoints, variability |
| Simon Furney
| Kings College London |
genetics, neuroimaging |
| Allyson Gage
| Forest Research Institute |
Sever Impairment Battery; moderate to severe AD |
| Anthony Gamst
| University of California, San Diego |
longitudinal data analysis, quasi-likelihood, informatics |
| Eric Garland
| GE Healthcare |
Software Imaging |
| Michael Garrett
| Garrett Technologies Inc. |
sequenced mri data |
| Christian Gaser
| University of Jena |
classification |
| Stefan Gazdzinski
| Center for Imaging of Neurodegenerative Diseases (CIND) |
body weight, glucose, aging, dementia |
| Gianluca Gemme
| Istituto Nazionale di Fisica Nucleare |
Hippocampus, Segmentation, Atrophy |
| Emmanuelle Genin
| Inserm |
genetic |
| Devon Gessert
| UCSD - ADCS |
na |
| Duncan Gillies
| Impeial College London |
Volume change quantification |
| Jean-Louis Giordano
| Chalmers |
Brain Alzheimer Image Analysis |
| Darren Gitelman
| Northwestern University |
VBM, covariance |
| Ben Glocker
| Technische Universit?t M?nchen |
Image Registration |
| Michael Godbey
| University of Louisville |
longitudinal model, change points |
| PRIYA GOEL
| Univ of Texas Health Science Center |
atlas evaluation |
| Michael Gold
| GlaxoSmithKline |
Anomia, stochastics, volumetrics |
| Terry Goldberg
| Feinstein Institute/AECOM |
MCI, Alzhemiers disease, savings, memory |
| Jesus Gomar
| The Feinstein Institute for Medical Research |
VBM, Genetic polymorphism |
| Roberto Gomeni
| GSK |
Disease progression, longitudinal model, placebo response |
| Theresa Good
| University of Maryland Baltimore County |
SERS, ADDL |
| Juan Manuel Gorriz
| University of Granada |
Image processing, Random forest |
| Igor Grachev
| Merck |
PET, MRI |
| Emily Grandey
| Memory Wellness |
Alzheimer's; mild cognitive impairment;cognitive complaint,Parkinson's Disease |
| Katherine Gray
| Imperial College London |
Alzheimer's disease; early diagnosis |
| Barry Greenberg
| Neurochem, Inc. |
biomarker |
| Keith Gregg
| Elan Pharmaceuticals, Inc. |
statistics |
| Michael Greicius
| Stanford University |
genes, structure |
| Joan Greve
| Genentech Inc |
AD, PET, MRI, mouse, human |
| Douglas Greve
| MGH |
Interhemispheric |
| John Grinstead
| Siemens Medical Solutions |
T1 image quality |
| Eric Guedj
| CHU Timone |
PET |
| Hongbin Guo
| Arizona State University |
PET, quantification, parametric imaging |
| Christian Habeck
| Columbia Un |
multivariate analysis, ROC curve, replication |
| Anna Hallerbach
| Chalmers University of Technology |
Alzhreimer MRI project |
| Per Hammarstrom
| Linkoping University |
amyloid, imaging |
| Harald Hampel
| Trinity College Dublin |
biomarker, CSF, PET, MRI, |
| Jian Han
| Bristol-Myers Squibb Company |
exploratory |
| Tony Han
| Brain Research |
Alzheimer's disease, brain imaging, spm |
| Yousef Hanna
| GE Healthcare |
GE |
| John HARDY
| UCL Institute of Neurology |
genetics, whole genome association |
| Peter Hardy
| University of Kentucky |
iron, T2, alzheimers, plaque |
| Jon Haron-Feiertag
| UCSF |
image registration |
| Danielle Harvey
| Unversity of California, Davis |
biostatistics |
| Danielle Harvey
| University of California, Davis |
biostatistics |
| Steven Hass
| Abbott Laboratories |
healthcare utilization, modeling |
| Shizuo Hatashita
| Shonan-Atsugi Hospital & Clinic |
PIB PET |
| Yong He
| Beijing Normal University |
cortical thickness, connectivity, network analysis, biomarker |
| Huiguang He
| Institute of Automation, Chinese Academy of Scicences |
fMRI, DTI, Medical Image Processing |
| Rolf Heckemann
| Imperial College London |
anatomical segmentation, morphometry, volumetry, |
| Judith Heidebrink
| University of Michigan |
Alzheimer disease |
| Suzanne Hendrix
| Pentara Corporation |
ADAS-cog sensitivity |
| David Henley
| Eli Lilly and Co. |
Alzheimer's disease |
| Karl Herholz
| University of Manchester |
Alzheimer's disease, Mild cognitive impairment, 18F-FDG-PET |
| Christopher Hess
| UCSF |
neuroradiology, neurodegenerative, diffusion |
| Jennifer Hilborn
| York University |
Dispersion, Variability, Cognition, Intraindividual variability, MCI, AD |
| Derek Hill
| IXICO Ltd |
Neurodegeneration trials |
| Hampus Hillerstrom
| Harvard-MIT Division of Health Sciences & Technology |
trial design Alzheimer mild cognitive impairment |
| Jeremy Hobart
| Peninsula College of Medicine and Dentistry |
Rating scales, psychometrics, reliability, validity, Rasch analysis |
| John Hoffman
| University of Utah |
FDG-PET, SPM group analysis |
| Daniel Holder
| Merck Research Laboratories |
Biomarkers |
| David Holtzman
| Washington University |
CSF biomarkers |
| Mark Horsfield
| University of Leicester |
software |
| Vincent Hradil
| Abbott |
MRI Image Analysis |
| Xiaolan Hu
| Pfizer Inc |
Meta-analysis |
| Xiaolan Hu
| Pfizer |
genetics |
| Fude Huang
| Institute of Neuroscience, Chinese Academy of Sciences |
alzheimer, hippocampus, CA1 |
| Shu-Pang Huang
| Bristol-Myers Squibb Co. |
statistics, biomarker |
| Juebin Huang
| Case Western Reserve University |
White Matter |
| Xudong Huang
| Brigham and Women's Hospital |
data fusion, biomarker, Alzheimer's disease |
| Rebecca Hubbard
| University of Washington |
statistical methods |
| Matthew Huentelman
| Translational Genomics Research Institute |
genomics |
| Orest Hurko
| University of Dundee |
Medication |
| Stephen Hurt
| Weill Medical College of Cornell University |
CDR |
| Stefan Huwer
| Siemens AG |
morphometry, ad |
| Susan Huyck
| Schering Plough |
biomarker |
| Scott Hwang
| Emory University Hospital |
image analysis, mri |
| Karl Ihrig
| Nevada Genome Exploration Corporation |
genome wide association study |
| Yasuhiko Ikari
| Institute of Biomedical Research and Innnovation |
ikariyasuhiko |
| Fred Immermann
| Wyeth Research |
variability, correlation, regression modeling |
| Lurdes Inoue
| University of Washington |
statistical methods, longitudinal data, risk factors, neuroimaging markers |
| Philip Insel
| NCIRE |
power, rates of change |
| James Ireland
| 5AM Solutions, Inc. |
quantitative methodology, Alzheimer's disease, integrative, biomarkers |
| Michael Irizarry
| GlaxoSmithKline |
ADAS-cog |
| Suhandi Irwan I
| Nanyang Technological University |
Brain Imaging Limitation |
| Taro Ishibashi
| The University of Tokyo |
clinical data, biomarker data, imaging data |
| Kenji Ishii
| Tokyo Metropolitan Institute of Gerontology |
PIB FDG PET Japan-ADNI |
| Kaori Ito
| Pfizer Inc |
disease progression |
| Takeshi Iwatsubo
| University of Tokyo |
Japan, J-ADNI |
| Clifford Jack
| Mayo Clinic |
FDG, PIB |
| Patrick Jacobs
| Perceptive Informatics |
human, perceptive |
| Mark Jacobson
| Veterans Affairs San Diego Healthcare |
MRI, morphometry, cognitive profile, MCI |
| Carl Jaffe
| NCI |
data interoperability |
| William Jagust
| UC Berkeley |
PET, ROI |
| Vineet Jain
| louisiana tech university |
temporal data mining |
| Luc Janssens
| J&J Pharmaceutical Research & Development, division of Janssen Pharmaceutica NV. |
Alzheimer's Disease Clinical Research Studies Variability |
| Hernan Jara
| Boston University Medical Center |
T2 Q-MRI |
| Danna Jennings
| Molecular NeuroImaging |
Healthy controls, cognitive battery |
| Bumseok Jeong
| Eulji University Hospital |
subcortex, surface model, longitudinal change |
| Tianzi Jiang
| Institute of Automation, Chinese Academy of Sciences |
Alzheimer's Disease, Cortical Thickness and Complexity, Brain Networks |
| Joseph Johnson
| University of Minnesota Duluth |
BACE1 |
| Sterling Johnson
| University of Wisconsin |
CSF volume, VBM, rates of atrophy |
| David K Johnson
| University of Kansas |
cognition, longitudinal analysis, Alzheimer's disease |
| Timothy Johnson
| University of Michigan |
Bayesian statistics, classification, Bayesian non-parametrics, fMRI data |
| Sandhya Joshi
| University institute of engineering |
Alzheimer's Parkinson |
| Per Julin
| AstraZeneca |
brain volumetry |
| Koki Kabu
| MICRON Inc. |
J-ADNI |
| Kristin Kahle-Wrobleski
| Eli Lilly & Co. |
Alzheimer's disease, functional ability, longitudinal changes |
| Hanimi Reddy Kallam
| Nanyang Technological University |
Brain, AD, Cortical thickness |
| Tomohiro Kaneta
| University of Washington |
heterogeneity, interval change, MCI, Alzheimer |
| Kwabena Tontoh Kankam-Yeboah
| GE Healthcare |
ADNI |
| Dimitrios Kapogiannis
| National Institute on Aging |
volumetrics, CSF biomarkers |
| Elissaios Karageorgiou
| University of Minnesota |
biomarker development; cross-validation; overfitting |
| David Karow
| ucsd |
PET |
| Elyse Katz
| Pfizer |
GWAS Biomarker Clinical |
| Sandeep S Kaushik
| International Institute of Information Technology |
Dementia, MRI analysis |
| John Kauwe
| Washington University School of Medicine |
cerebrospinal fluid, amyloid, tau |
| Atsushi Kawaguchi
| Kurume University |
biostatistics, covariate adjustment |
| Fumio Kawaguchi
| spectratech Inc. |
hinodemachi |
| Hirofumi Kawakami
| GE Healthcare |
J-ADNI |
| Shoji Kawashima
| National Center for Geriatrics and Gerontology |
SEAD-J, ADNI, Alzheimer's disease, FDG-PET |
| Thomas Kelleher
| Bristol-Myers Squibb Co |
exploratory analyses, clinical trial endpoints |
| Geoffrey Kerchner
| UCSF |
mri, alzheimer's disease, hippocampus, mild cognitive impairment |
| Andre Khalil
| University of Maine |
White matter, image analysis, wavelet transform, multifractal |
| Iya Khalil
| Gene Network Sciences |
disease causlity, reverse engineering, network inference, biomarkers |
| Deepak Khatry
| MedImmune |
biomarkers, diagnostics, clinical trials |
| Neil Killeen
| University of Melbourne |
data management |
| Ron Killiany
| Boston University School of Medicine |
regions of interest, neocortex, hippocampus, entorhinal cortex |
| JOONYOUNG KIM
| Bristol-Myers Squibb Company |
PET |
| Daniel Kimberg
| University of Pennsylvania |
database, structural mri |
| Tokunori Kimura
| Toshiba Medical Systems |
MR company, qaulity check |
| Richard King
| University of Texas at Dallas |
Morphometric, Volumetric, Atrophy, Dimensionality |
| Justin Kirby
| National Cancer Institute |
n/a |
| DONALD KLEIN
| COLUMBIA UNIVERSITY |
CLINICAL TRIAL POTENTIAL METHODOLOGY |
| Michael Klimas
| Merck |
segmentation, patterns, MRI, PET |
| Karin Knesaurek
| The Mount Sinai Medical Center |
restoration of PET images |
| Juha Koikkalainen
| VTT Technical Research Centre of Finland |
spatial normalization |
| Michel Koole
| UZ Leuven |
brain PET automatic analysis |
| Nickolas Kotran
| Hitachi Medical Systems America |
HMC JADNI |
| Julie Kuo
| UC Davis |
epidemiology, learning effects, aging, elderly, Alzheimer's |
| Genevieve Laforet
| Abbott |
ADAS-Cog |
| Bianca Laita
| Point Loma Nazarene University |
statistics |
| Rayhan Lal
| U.C. Berkeley |
PET ROI |
| Susan Landau
| UC Berkeley |
PET FDG ROI |
| Seth Landefeld
| UCSF, SFVAMC |
prognosis, dementia, cognitive impairment, functional decline |
| Jaren Landen
| Pfizer |
Image analysis, MCI conversion to AD |
| Richard Lane
| University of Arizona |
PET ICD amygdala |
| Jessica Langbaum
| Banner ALzheimer's Insitute |
FDG PET |
| Pedro Latorre Carmona
| Jaume I University |
image processing, 3D volumes |
| Karen Lau
| Alliant International University |
neuropsychological assessments |
| Michelle Lax
| GE Healthcare |
C11 PIB |
| Richard Leahy
| University of Southern California |
Computational nueroanatomy, cortical analysis, |
| Dongsoo Lee
| Commonwealth Gerontology Institute |
Prevalence, minority, aging |
| Noah Lee
| Columbia University |
temporal analysis, validation, image analysis |
| Daren Lee
| UCLA |
registration |
| Jae-Hong Lee
| Asan Medical Center, Univ. of Ulsan College of Medicine |
Alzheimer's disease, amyloid load, white matter ischemia, PiB-PET, MRI |
| Julien Lef?vre
| CEA - DSV/I2BM/Neurospin |
Cortical folding, sulci |
| Stamatis Lefkimmiatis
| National Technical University of Athens |
image restoration |
| Gabriel L?ger
| Universit? de Montr?al |
cirtical thickness Civet progression |
| Herve Lemaitre
| NIMH/NIH |
Aging, neuroanatomy, MRI |
| Robert Lenz
| Abbott Labs |
MRI, biomarkers, CSF, PET |
| Gayle Lester
| National Institutes of Health |
MR Images |
| Allan Levey
| Emory University |
prediction, diagnosis |
| Sam Li
| University of Pennsylvania |
metabolites, metabolic profiling |
| Gang Li
| The Methodist Hospital Research Institution |
image analysis |
| Chin-Shang Li
| University of California, Davis |
Biostatistician |
| Yi Li
| NYU school of medicine |
FDG-PET PIB-PET MRI |
| tieqiang Li
| Karolinska University Hospital |
vbm gender |
| Xingfeng Li
| U678 INSERM, CHU Piti?-Salp?tri?re |
image processing |
| Lichen Liang
| University of Minnesota |
SVM |
| Jenny Libien
| State University of New York- Downstate Medical Center |
advanced decision support |
| Lan Lin
| asu |
AD |
| Ling-chih Lin
| University of Rochester |
MRI, biomarker, VBM, brain phantom, biostatistics |
| lei lin
| Zhejiang University |
VBM MRI |
| Tao Liu
| The University of New South Wales |
MRI |
| Pu Liu
| Johnson & Johnson |
Biomarker AD Early Diagnostic |
| Tao Liu
| School of Design, Communication and Information Technology |
MRI;AD;cerebral |
| Lian Liu
| Merck & Co., Inc. |
Alzheimer's Disease |
| Tao Liu
| The University of Newcastle |
neuroimaging;MRI |
| Daniel Llano
| Abbott Laboratories |
CSF, MRI |
| Raymond Lo
| UC Berkeley |
MCI, PET, predictors, |
| Elie Lobel
| e(ye)BRAIN |
alzheimer, atrophy |
| Veronika Logovinsky
| Eisai Medical Research Inc. |
Bertina, Alzheimer |
| Augusto Lois
| Jaden Bioscience |
Patterns, biomarkers, disease stage |
| ziyi long
| Dongzhimen Hospital |
MRI AD |
| Tong Longzheng
| Capital Medical University |
morphologic features; high-dimensional classifier; MCI; AD |
| Jeffrey Looi
| Australian National University Medical School |
caudate, putamen, neostriatum, corticostriatal |
| Po-Haong Lu
| UCLA |
Tensor-based morphometry, longitudinal changes, MCI, AD, normal aging |
| Roger Lundqvist
| Uppsala Imanet AB/ GE Healthcare |
PIB, MRI, AD, biomarkers |
| James Luo
| NIBIB |
Meta data integration |
| John Lynch
| UCSF |
imaging epidemiology |
| LEI MA
| Schering-Plough |
biomarker |
| Scott Mackin
| University of California, San Francisco |
depression, MRI, disability, cognition |
| Brian Madsen
| The MathWorks |
Statistical analyses, data sets |
| Nobuhisa Maeno
| National Institute for Longevity Sciences, NCGG |
AD, amyloid imaging, MRI, cognitive examination |
| Silvio Maglio
| Universita' del Salento |
si118ma353 |
| Ralph Paul Maguire
| Pfizer Global Research & Development |
imaging |
| Mawlan Mahmut
| national institute for longevity sciences |
MRI　PET　Alzheimer mild cognitive inperment |
| John Majercak
| Merck Research Laboratories |
Fluid biomarkers, CSF, Risk Factors |
| Joseph Maldjian
| Wake Forest University School of Medicine |
Brain phantom MRI |
| Jean-Francois Mangin
| CEA |
sulci morphometry |
| Daniel Marcus
| Washington University School of Medicine |
segmentation, automation |
| Kenneth Marek
| Institute for Neurodegenerative Disorders |
PIB, FDG, PET, MCI |
| Marjorie Marenberg
| Thomas Jefferson University |
lipids, cognitive performance, executive function, mild cognitive impairment |
| Pawel Markiewicz
| The University of Manchester Wolfson Molecular Imaging Centre |
PCA, FDA, FDG PET |
| Gad Marshall
| Brigham and Women's Hospital |
PIB PET, FDG PET, APOE |
| Ferenc Martenyi
| Lilly Research Laboratories |
cholinesterase inhibitors, Abeta1-42, cerebrospinal fluide, Alzheimer's Disease |
| Fanny Marticke
| Charite Berlin |
MR-based partial volume effect correction of PET images |
| fernando martin
| uniovi student |
segmentation genetic algorithms |
| Jacob Martin
| Georgetown University Medical Center |
information retrieval, singular value decomposition, classification |
| Andrea Marton
| University of P??©cs |
MR spectroscopy, hippocampus, temporal lobe epilepsy |
| George Marzloff
| Mount Sinai School of Medicine |
Fourier-wavelet PET |
| Mara Mather
| University of Southern California |
depression, prefrontal |
| Chester Mathis
| University of Pittsburgh |
PIB |
| Dawn Matthews
| Abiant, Inc. |
HipMask, PET, Alzheimers, MCI, FTD |
| Mary Pat McAndrews
| University Health Network |
hippocampus, functional imaging |
| Linda McEvoy
| University of California, San Diego |
MRI, PET, morphometry, thickness, prediction |
| Joseph McQuail
| Wake Forest University |
Biological parametric mapping, executive function |
| Romulo Meira
| Universidade Federal da Bahia |
Teaching |
| Valeria Mele
| University of Naples Federico II |
segmentation, PET, MRI, software |
| Jere Meredith
| Bristol-Myers Squibb |
CSF biomarkers |
| Dorit Merhof
| Siemens Molecular Imaging |
statistical evaluation of PET data, anatomical biomarkers of AD disease |
| Roustem Miftahof
| Pohang University of Science and Technology |
none |
| Arthur Mikhno
| Columbia University |
Alzheimers, PET, diagnosis, MRI, voxel |
| Josephine Minnicino
| Boston University Medical Center |
Alzheimer's Disease, Micro-hemorrhage |
| Mubeena Mirza
| UCLA |
cortical morphometry |
| Ananth Mohan
| GE Healthcare |
applications, software solutions |
| Norhashimah Mohd Saad
| Universiti Teknologi Malaysia |
alzheimer's disease |
| laura monno
| universit?? degli studi di Bari |
Alzheimer, image analysis, texture |
| Andreas Monsch
| Memory Clinic-Neuropsychology Center |
neuropsychology, clinical, quantitative MRI |
| Giovanni Montana
| Imperial College |
non-stationary cluster inference "imaging genetics" |
| Marie-Louise Montandon
| Geneva University Hospital |
PET, neuroimaging |
| Dana Moore
| Weill Medical College of Cornell University |
cerebrospinal fluid, ventricles, ventricular, volumetric |
| Parmida Moradi Birgani
| SRBIAU |
MRI, Cerebral diseases, Volumetric segmentation. |
| Bruce Morimoto
| Allon Therapeutics Inc |
cognitive instruments, biomarkers, therapeutic intervention |
| Kristen Morris
| Elan Pharmaceuticals |
vasogenic cerebral edema, MRI, alzheimer's disease |
| B?n?dicte Mortamet
| CIBM - SIEMENS (leaded by Gunnar Krueger, PhD) |
morphometry |
| Javed Mostafa
| University of North Carolina at Chapel Hill |
image databases, image retrieval, visual mining, algorithms |
| Marco Mozzoni
| University of Pavia |
neglect, ad |
| Notger Mueller
| Otto-von-Guericke University Clinic |
logistic regression, support vector machine, linear discriminate analysis |
| Michael Murphy MD, Ph.D
| TorreyPines therapeutics |
clinical research; biostatistics |
| Brian Murray
| Sunnybrook Health Sciences Centre - University of Toronto |
sleep REM sleep behavior disorder alertness |
| Amanda Myers
| University of Miami |
expression, genotype, eQTL, neuropathology |
| ANIL NAIR
| BOSTON UNIVERISITY |
adni |
| Adam Naj
| University of Miami Miller School of Medicine |
GWAS; Alzheimer Disease; dementia biomarkers |
| Kaoru Nashiro
| University of Southern California |
cognition emotion memory |
| Dennis Nelson
| MIMvista Corp |
PET, SPECT, MR, image analysis |
| Kiyotaka Nemoto
| University of Tsukuba Hospital |
VBM |
| Jasmine Nettiksimmons
| University of California - Davis |
predict, cognitive decline |
| Scott Neu
| UCLA |
anatomical point landmark, automation, svd, seed points |
| Art Noda
| Stanford University |
ROC biomarkers |
| JANIS O'MALLEY
| University of Alabama Birmingham |
PET, Quantitation, |
| Thomas Obisesan
| Howard University Hospital |
cardivascular disease, Alzheimer's disease |
| Joy Occhiuto
| Perceptive Informatics |
PET |
| Lasse Riis Oestergaard
| Aalborg University |
cortical thickness, surface based analysis |
| Joonmi Oh
| Synarc |
Clinical trials |
| Ozioma Okonkwo
| Brown Medical School |
Cerebral atrophy, vascular burden, WMH, functional change, MCI |
| Marcel Olde Rikkert
| Radboud University Medical Centre |
Trajectories of disease, dementia, comorbidity |
| Julian Ollesch
| Max-Planck Research Unit for Enzymology of Protein Folding |
fibrillation, amyloid genesis, abeta |
| John Ollinger
| University of Wisconsin Madison |
dicom python software |
| Salvador Olmos
| Zaragoza University |
morphometry, diffeomorphism |
| Susanne Ostrowitzki
| F.Hoffmann-La Roche Ltd |
biomarkers, disease progression |
| Annahita Oswald
| University of Munich |
Feature Selection, Classification, Alzheimers Disease, Mild Cognitive Impairment |
| Victor Otcheretko
| HSC |
Prodromal AD |
| Brian Ott
| Rhode Island Hospital -- APC 6 |
Alzheimer, mild cognitive imapirment, hydrocephalus, amyloid, tau, MRI |
| Sebastien Ourselin
| University College London |
cortical thickness, PIB |
| Judy Pa
| University of California, San Francisco |
mild cognitive impairment, neuroimaging |
| Heath Pardoe
| Brain Research Institute |
VBM, multi-site |
| Daniel Paredes
| NIH-NINDS |
neonatal, hippocampus, striatum, amygdala, pre-frontal cortex |
| Douglass Parker
| UCLA |
classification |
| Ramin Parsey
| Columbia University |
Prediction |
| James Paskavitz
| Perceptive Informatics |
SUV and VBM |
| Maria Pastor
| University of Navarra |
rTMS rehabilitation Parkinson?s disease |
| James Patterson
| LSUHSC - Shreveport |
Alzheimer's disease, PET, MRI, CDI |
| Jon Pauls
| Synarc |
cortical atrophy |
| Mikolaj Pawlak
| Poznan University of Medical Sciences |
Multiple Sclerosis, Alzheimer Disease |
| Guerry Peavy
| UCSD School of Medicine |
hippocampus, stress, cortisol, dementia, Alzheimer's |
| Yahong Peng
| Merch Research Labs |
mixed effects model |
| Jean louis Pepin
| C.H.U.Li?ge |
electrophysiology, MRI |
| Amy Perkins
| University of Pennsylvania/Philips Research |
PET, MR, fusion |
| Ronald Petersen
| Mayo Clinic |
mild cognitive impairment, Alzheimer's disease |
| Gerasimos Petratos
| University of Utah |
Outcomes, Functional, Behavioral |
| Jorge Pezoa
| University of New Mexico |
rician distribution, denoising MRI |
| Eve Pickering
| Pfizer, Inc |
biomarkers |
| Mauro Piovezan
| universidade federal do parana - hospital de cl?nicas |
mauro piovezan |
| Elizabeth Pirraglia
| NYU Medical Center |
PET MRI CSF norms |
| Mika Pollari
| Helsinki University of Technology |
registration, cross-sectional and longitudinal analysis |
| Michael Pontecorvo
| Avid Radiopharmaceuticals |
Amyloid, PET, Alzheimer's disease |
| Holly Posner
| Pfizer |
psychometric, Rasch, cognition |
| Steven Potkin
| University of California, Irvine |
Alzheimer's disease, neuropsychological examinations, rate of atrophy |
| Stephane Poulin
| Massachusetts General Hospital |
NPI, Alzheimer's disease, brain MRI |
| Fari Pour Ansari
| UCSF |
Michael Weiner clincal data |
| Joseph Preston
| University of Utah |
LDDMM, atlas, fluid deformation |
| Yili Pritchett
| Abbott Laboratories |
Clinical trial results |
| Ruolun Qiu
| Pfizer, Inc |
disease progression |
| Constance Dean Qualls
| State University of New York College at Buffalo |
language in aging, cognitive-linguistic aging, dementia |
| Jose Rabey
| Asaf Harofe Mwedical Center |
alzheimer progression analysis |
| Rozalin Rabieian
| UCLA |
Alzheimer's |
| V.P.Subramanyam Rallabandi
| National Brain Research Centre |
tissue classification and segmentation |
| Amy Ramage
| University of Texas Health Science Center at San Antonio |
SEM, connectivity |
| Christopher Randolph
| Loyola University Medical Center |
neuropsychology change |
| Richard Raubertas
| Merck & Co. |
data download |
| David Raunig
| Pfizer |
Imaging Biomarker |
| Laura Ravasi
| Universit? de Lille 2 Facult? de medecine |
Alzheimer's disease ; brain metabolism |
| Debashis Ray
| Apollo Gleneagles Hospital |
NMDA, Memantine,Dopamine |
| Hana Razak
| UiTM |
clinical data for alzheimer's disease |
| Bhaskar Rege
| Eisai Medical Research, Inc. |
Population PK/PD, Disease modeling |
| Anthonin Reilhac
| Biospective |
simulation, processing tools |
| Lucas Restrepo
| UCLA Medical Center |
immunosignatures, peptide microarray, antibody |
| Alessandra Retico
| Istituto Nazionale di Fisica Nucleare |
VBM |
| C. Harker Rhodes
| Dartmouth-Hitchcock Medical Center |
GWAS candidate gene analysis |
| William Riddle
| Vanderbilt University |
Deformation Based Morphometry |
| Michele Ries
| University of Wisconsin - Madison |
Mild Cognitive Impairment, MRI |
| Francesco Rinaldi
| IASI |
feature selection; neural networks |
| Matt Rischall
| University of Pittsburgh |
Alzheimer's |
| Ian Robertson
| Trinity College Dublin |
Cognitive Aging, Mild Cognitive Impairment, Logical Memory, Premorbid IQ, NART |
| Weining Robieson
| Abbott Laboratories |
ADAS-Cog |
| Lawrence Rodichok
| AstraZeneca Pharmaceuticals |
pharmaceutical trials |
| Norberto Rodriguez
| Universitary Hospital Ntra. S? de Candelaria HUNSC |
vbm, neurosychological |
| Michael T. Rogan
| Columbia University |
biomarkers, knowledge management |
| Elizabeth Rogers
| optical BioScience |
alzheimers |
| Ignacio Rojas
| University of Granada |
intelligent system, automatic diagnosis |
| Klaus Romero
| The Critical Path Institute |
Pharmacometrics, modeling and simulation |
| Jonathan Rosand
| Massachusetts General Hospital |
GWAS, genetics, APOE |
| Allyson Rosen
| Stanford University |
aging, MCI, AD |
| Paul Rosenberg
| Johns Hopkins University School of Medicine |
Depression, Alzheimer's, PIB |
| Fran?ois Rousseau
| CNRS |
registration, image enhancement |
| Christopher Rowe
| Austin Health |
PIB, AIBL |
| Prasun Roy
| National Brain Research Center |
MRI, texural analysis, MMSE, CSF, impaired neurogenesis |
| Daniel Rubin
| Stanford Univ |
RDF |
| Daniel Rueckert
| Imperial College |
image registration, morphometry |
| Agustin Ruiz
| neoCodex /Fundaci? ACE |
genomics, epistasis, snp analysis, susceptibility |
| Henry Rusinek
| New York University |
PET, MRI, glucose metabolism, atrophy, regional analysis |
| Ryan Russon
| University of Utah |
surface-based analysis, diffeomorphism, alzheimer's |
| Lee Ryan
| University of Arizona |
obesity, VBM, normal aging |
| Laurie Ryan
| National Institute on Aging |
ADNI |
| Ahmed Saad
| Simon Fraser University |
Segmentation, Visualization, 3D+Time |
| M Sabarimalai Manikandan
| Indian Institute of Technology Guwahati |
Information-theoretic analysis for segmentation |
| Michael Sachs
| University of Washington |
Data reduction |
| Martin Sadowski
| New York University School of Medicine |
neuropsychological testing, imaging |
| David Salat
| MGH/Martinos Center |
aging, alzheimer, mri, hippocampus, white matter |
| David Salmon
| University of California, San Diego |
learning, recall, recognition |
| Hugh Salter
| AstraZeneca R&D S?dert?lje |
Genetics |
| Jeffrey Saltzman
| Merck & Company |
Amyloids, Morphology, Tau |
| Vika Samarina
| Stanford/VA Hospital |
WMS-R Logical Memory, memory decline, normal controls, MCI, AD |
| Kumar Sambamurti
| MUSC |
amyloid vitreous aqueous |
| ailton santa barbara
| centro de pesquisas renato archer |
medical imaging visualization segmentation |
| Hajime SATO
| The University of Tokyo Graduate School of Medicine |
J-ADNI, statistical analysis, |
| Daniel Saumier
| McGill University |
ADAS-cog, variability |
| Ikuhisa Sawada
| NEDO |
instruction |
| Andrew Saykin
| Indiana University School of Medicine |
MRI, PET, genetics, pattern recognition |
| Eric Schadt
| Sage |
GWAS eSNPs networks |
| J. David Schaffer
| Philips research |
clinical decision support systems |
| Douglas Scharre
| Ohio State University |
Screening test |
| Nick Schmansky
| Massachusetts General Hospital |
freesurfer, cortical thickness |
| Mark Schmidt
| Johnson and Johnson PRD |
clinical trials, multivariate analysis, integrated database |
| Julia Schnabel
| University College London, Centre for Medical Image Computing (CMIC) |
IBIM, shape analysis, modelling, registration, feature detection |
| Lon Schneider
| University of Southern California |
demographics, Alzheimer's disease |
| Jonathan Schott
| Institute of Neurology, UCL |
MRI, volumterics, ApoE, MCI |
| Prof. Dr. Hauke Schramm
| University of Applied Sciences Kiel |
Landmark detection, Generalized Hough Transform, Log-linear model |
| Craig Schwartz
| UCLA |
brain structure |
| Adam Schwarz
| Eli Lilly and Company |
pharmaceutical, biomarker, MRI, analysis |
| Michael Schwarzschild
| Massachusetts General Hospital |
urate, uric, purines, antioxidant, progression, biomarker, neuroprotectant |
| Michael A. Schwarzschild
| Massachusetts General Hospital |
urate, uric, purines, antioxidant, progression, biomarker, neuroprotectant |
| Jeffrey Seeburger
| Merck & Co., Inc. |
Alzheimer's; cognition; biomarker |
| Ravi Seethamraju
| Siemens Medical Solutions |
MR |
| Flavio Seixas
| Universidade Federal Fluminense |
PET imaging, ADHD, SPM |
| Matthew Senjem
| Mayo Clinic |
Mayo Clinic, PIB, MRI |
| Gopalan Sethuraman
| Eli Lilly & Company |
Data Download Training |
| Jeffrey Sevigny
| Merck Research Labs |
cognition, biomarkers |
| Soheil Shams
| BioDiscovery |
microarray, copy number profiling, neurogenetic disorders, gene expression |
| Leslie Shaw
| Univ of PENN Medical Center |
correlation analyses, biomarkers |
| Jaba Sheela
| PEC |
pattern recognition , AD,MRI,classification |
| Kaikai Shen
| CSIRO ICT Centre |
Segmentation, registration, longitudinal study |
| weijia shen
| National University of Singapore |
medical image segmentation |
| David Shera
| Merck Research Laboratories |
biomarker |
| Michelle Sherman
| Perceptive Informatics |
Imaging |
| John Sherman
| Colorado Springs Imaging |
mathematical function, parietal morphometry, Alzheimers |
| kwang-shi Shu
| JJPRD |
Biomarker, Clinical Scale |
| Catherine Shuler
| Eli Lilly |
symptoms |
| Rene Siegel
| Cedars-Sinai Medical Center |
PET, normal |
| Eric Siemers
| Eli Lilly and Company |
biomarkers |
| James Signorovitch
| Analysis Group Inc. |
Image summary statistics; discrimination |
| Margarida Silveira
| Institute for Systems and Robotics / IST |
pattern recognition, machine learning, curse of dimensionality |
| Michael Silver
| New York University |
longitudinal studies, clinical trials, biomarkers |
| Daniel Silverman
| UCLA David Geffen School of Medicine |
Brain, Metabolism, PET, longitudinal, neuropsych |
| Andy Simmons
| Kings College London Institute of Psychiatry |
ADNI AddNeuroMed MMSE ADASCOG |
| Jason Simon
| Eisai Global Clinical Development |
Eisai |
| Ivor Simpson
| University of Oxford |
Biomarkers |
| Amardeep Singh
| Imperial College London |
Cortical Structure, Pattern Recognition, surface-based analysis |
| Nikhil Singh
| Scientific Computing and Imaging Institute |
adni sci |
| Simer Preet Singh
| University of Alabama at Birmingham |
dolichoectasia |
| Benjamin Sintay
| Henry Ford Hospital |
PDE methods, shape analysis, geometry, statistical analysis, characterization |
| Saad Sirohey
| GE Healthcare |
Alzheimer 3D-SSP |
| Niclas Sj?gren
| AstraZeneca |
Sample size calculation; progression markers in MCI and AD |
| michael slifer
| Univerisity of Miami |
Genetics, depression, psychosis |
| Ingrid Sluimer
| VU University Medical Center |
image processing, grid, automation |
| Gary Small
| UCLA |
PET MRI education |
| Mark A. Smith
| Case Western Reserve University |
diagnostic, disease progression |
| Michael Smith
| CorTechs Labs Inc |
MRI brain volumetric |
| Charles Smith
| University of Kentucky |
normal, mri, structural |
| Benjamin Smith
| Simon Fraser University |
segmentation, visualization, kinetic parameters |
| Timothy Smyth
| Northcoast Nuclear Medicine |
PET, fMRI, SPECT, alzheimer's disease, pre treatment, post treatment |
| Sarah Snow
| university of westminster |
AD |
| Peter Snyder
| University of Connecticut |
ApoE, Alzheimer's Disease, Evolutionary Psychology, Pleiotropism |
| Holly Soares
| Pfizer |
Biomarkers |
| Octavian Soldea
| Sabanci University |
Volumetric analysis, structural segmentation of MR and CT images |
| Octavian Soldea
| Sabanci University, Turkey |
volumetrıc segmentation |
| Paul Solomon
| Williams College |
Hippocampal volume, memory, savings |
| Changhong Song
| Hoffmann-La Roche Inc. |
Biomarkers Alzheimer's disease |
| Xiaowei Song
| Dalhousie University |
Alzheimer's disease, aging, brain lesion index, T1-weighted MRI, T2-weighted MRI |
| Greg Sorensen
| MGH |
MRI variability |
| Maria Vittoria Spampinato
| MUSC |
VBM, alzheimer, biomarkers |
| Christian Spenger
| Karolinska Institutet |
cortical thickness, B-map |
| Reisa Sperling
| Brigham and Women's/Massachusetts General Hospital |
amyloid imaging |
| Ren??© Spiegel
| Memory Clinic |
MCI trajectories; prediction of dementia; cognitive decline |
| Sandro SQUARCIA
| Laboratorio di Fisica e Statistica Medica |
Image fusion, neuroimages, Alzheimer |
| Larry Squire
| University of California, San Diego |
memory |
| Roger Staff
| University of Aberdeen |
Ageing Brain, shape analysis |
| Isaac Stephen
| BU , Graduate Medical Science |
AD, Non-AD - Brain, WM, CSF , T2, DTSE - MRI |
| Yaakov Stern
| Columbia University |
PCA prediction |
| Cynthia Stonnington
| Mayo Clinic |
Alzheimer?s disease; multivariate; machine learning; relevance vector regression |
| Oliver Strbak
| Institute of Experimental Physics |
iron oxides, MRI, diagnosis, neurodegenerative disease |
| Colin Studholme
| U.C.S.F./VAMC |
Deformation Morphometry |
| Scot Styren
| Pfizer Inc. |
PIB MRI cognition |
| Morihiro SUGISHITA
| The University of Niigata Rehabilitation Graduate School |
test, normal , MCI, AD, memory |
| kazuyuki SUGISHITA
| Onai Hospital |
MCI, AD, conversion |
| Wei Sun
| University of North Carolina |
multiple loci mapping |
| Karen Sundell
| Eli Lilly and Company |
Clinical Trial |
| Momoko Takahashi
| The University of Tokyo |
age prediction, SVM, GP |
| Tetsuhiko Takahasi
| hitachi Medical corporation |
MRI |
| Tomoko Takeuchi
| shirayuri college graduate school doctral course |
tt77828 |
| Roger Tam
| The University of British Columbia |
Brain volume change |
| Isabelle Tamanini
| University of Fortaleza |
Diagnosis of Alzheimer's disease, Verbal Decision Analysis, Multicriteria |
| Tao Tan
| Technische Universiteit Eindhoven |
Segmentation Hippocampus |
| Tao Tan
| Eindhoven University of Techonolgy |
atlas-based, segmentation |
| Toshiro Tanaka
| Yokogawa Electic Corporation |
keens |
| Songyuan Tang
| University of North Carolina |
Registration |
| William Tanner
| Lazard Capital Markets |
biopharma company analyst |
| Xiaodong Tao
| GE Global Research Center |
Brain Segmentation, Morphological Change |
| Pierre Tariot
| Banner Alzheimer's Institute |
clinical trials |
| Tolga Tasdizen
| University of Utah |
tissue classification |
| Haythum Tayeb
| McGill University Faculty of Medicine |
alzheimer's disease, apathy, depression, delusions |
| Lisa Taylor-Reinwald
| Washington University |
Neuropathology Core |
| Amol Tendolkar
| Schering-Plough Corporation |
Population pharmacokinetics, PKPD, phase 0, AD biomarkers |
| Frank Tennigkeit
| Merz Pharmaceuticals |
cognition, drug effects |
| Frank Tennigkeit
| Merz Pharmaceuticals |
cognition, drug effects |
| Frank Thiele
| Philips Research Labs |
image analysis, FDG-PET, PIB-PET |
| Benjamin Thomas
| University College London Hospital |
FDG, PET, PET-MR, Amyloid |
| Ronald Thomas
| UCSD |
power analysis clinical trials |
| Paul Thompson
| UCLA School of Medicine |
MRI, brain, analysis, TBM |
| Lennart Thurfjell
| Uppsala Imanet AB |
PET, MR, diagnsotic featuers, classification |
| Naoki Tomita
| Institute of Development, Aging and Cancer, Tohoku University |
Cohort study, Time-dependent covariate, Longitudinal data, Failure time data |
| Gary Tong
| Bristol-Myers Squibb Co |
Tau, Abeta, MRI, PIB, PET |
| SOICHIRO TORIGOE
| Yokohama Stroke and Brain Center |
MRI dementia |
| MIZUTORI TOSHIYUKI
| Local government employee |
FDG2500 |
| Duygu Tosun
| Laboratory of Neuro Imaging, University of California, Los Angeles |
cortical morphometry, cross-sectional and longitudinal analysis |
| Saara Totterman
| 4Qimaging, LLC |
Automated segmentation |
| Paule Toussaint
| CHU Pitié-Salpetrière |
Alzheimer's disease, PET, metabolism, ADNI |
| Rochelle E Tractenberg
| Georgetown University School of Medicine |
latent variable analysis; alzheimer's disease, statistical models; tetrad |
| Emily Trittschuh
| Northwestern University, Feinberg School of Medicine |
morphometry - cortical thickness, visual search |
| Gavriil Tsechpenakis
| University of Miami |
image analysis |
| Erman Turan
| Chalmers Biomedical Engineer |
image processing, putamen, globus pallidus |
| Bruce Turetsky
| University of Pennsylvania |
orbital sulcus, olfactory sulcus, schizophrenia |
| Jessica Turner
| University of California, Irvine |
image quality, morphometry |
| Tuomas T?lli
| Helsinki University of Technology |
registration, deformation- and voxel-based analysis, classification |
| zasim uddin
| Rajshahi univesity |
MRI |
| Humito UESUGI
| The University of Niigata Rehabilitation Graduate School |
NL, MCI, AD, The tests |
| Lauren Ullrich
| Georgetown University |
hippocampal, entorhinal cortex, perirhinal cortex, structural imaging |
| Kannan Umadevi Venkataraju
| University of Utah |
Brain image analysis |
| Gokhan Uzunbas
| sabanci university |
basal ganglia, segmentation, iron deposition |
| Fernando Valdivia
| Centro de Recherche de l'Universit??© Laval Robert Giffard |
AD, MR |
| Marian van der Meulen
| University of Geneva |
hippocampal volumetry |
| hugo vanderstichele
| Innogenetics |
biomarkers csf plasma |
| Gabriel Vargas
| Roche |
Biomarkers |
| Minal Vasanawala
| VAPAHCS |
PIB biomarkers |
| Prashanthi Vemuri
| Mayo Clinic Rochester |
MRI |
| David Verbel
| Eisai Medical Research |
Natural history |
| Todd Verdoorn
| Orasi Medical, Inc. |
Dementia, diagnostic, electrophysiology |
| Charlotte Videbaek
| H.Lundbeck |
disease progression |
| Ignazio Vilardi
| IRCCS - Multimedica |
PET, Alzheimer, SPM |
| Javier Villanueva-Meyer
| Baylor College of Medicine |
PET normal volunteers |
| Pieter Jelle Visser
| University of Maastricht |
MCI |
| Shyam Visweswaran
| University of Pittsburgh |
genomics, interactions, epistasis, SNPs, prediction |
| Andrei Vlassenko
| Washington University School of Medicine |
FDG PET, MR |
| Maria Vounou
| Imperial College London |
brain images, human genome |
| Ralitza Vozdolska
| UCSD |
none |
| Kristine B Walhovd
| University of Oslo |
memory, morphometry, PET |
| Hong Wan
| Wyeth Research |
baseline, decline, rate |
| Jian Wang
| Eli Lilly and Company |
biomarker, disease modeling |
| Angela Wang
| University of Utah |
Alzheimer cognitive impairment memory decline MRI PET |
| Lei Wang
| Washington University School of Medicine |
PCA, subfields, deformation |
| Yue Wang
| Merck & Co. Inc |
Merck |
| yaping wang
| BRIC, university of north carolina |
segmentation, registration and classification, AD |
| Yongmei Michelle Wang
| University of Illinois at Urbana-Champaign |
structural and functional brain image analysis |
| Huali Wang
| Peking University Institute of Mental Health |
mild cognitive impairment, Alzheimer's disease |
| Li-San Wang
| University of Pennsylvania |
Genome-wide association studies |
| Alex wang
| lanzhou university |
AD |
| Michael Ward
| Genentech |
Pharmaceutical |
| Simon Warfield
| Children's Hospital and Harvard Medical School |
mri, image, segmentation, registration |
| Stephen Waring
| Univesity of Texas School of Public Health |
biomarkers, MCI, AD, MRI, hippocampus |
| Jeffrey Waring
| Abbott Laboratories |
CSF, tau, A-beta, BACE |
| Alan Waxman
| Cedars-Sinai Medical Center |
Brain PET scan |
| David Webb
| GlaxoSmithKline plc |
epidemiology |
| Michael Weiner
| ucsf |
MRI, PET |
| Michael Weiner
| UCSF/ SFVAMC |
Alzheimer's Disease, Mild Cognitive Decline |
| Li Wenjing
| Automation of Institution, Chinese Academy of Sciences |
VBM |
| Fabian Wenzel
| Philips Research |
PET analysis |
| Brandon Whitcher
| GlaxoSmithKline |
GSK |
| Jennifer Whitwell
| Mayo Clinic |
Alzheimer's disease; gradient warping; scaling; rates of atrophy |
| Demiana WilliamFaltaos
| FDA |
Disease progression modeling, disease modifying drugs |
| Julie Williams
| Cardiff University |
Genetics, GWAS, susceptibility genes |
| Brian Willis
| Eli Lilly and Co. |
MMSE, ADAS-cog, disease model |
| Beth Wilmot
| Oregon Health & Science University |
Genetics, Healthy Brain Aging |
| Thomas Wingo
| Emory Univeristy |
Proteomics, Parkinson's, Alzheimer's, family history |
| Nick Wisdom
| Oklahoma State University |
apolipoprotein |
| Gary Wisniewski
| Institute for Neurodegenerative Disorders |
Alzheimers, AD, PET, FDG |
| Heather Wiste
| Mayo Clinic |
ADNI, demographics |
| David Witt
| Bristol Myers Squibb |
imaging, image management |
| Nana Woerner
| UCSF/SFVA |
AD |
| Robin Wolz
| Imperial College London |
Alzheimer's disease, early diagnosis, statistical modeling |
| Ellen Woo
| UCLA |
NPI, CSF, cognition |
| Jongwook Woo
| CSULA |
jongwook |
| William Worstell
| PhotoDetection Systems, Inc. |
PET, attenuation correction |
| Andrew Worth
| Neuromorphometrics, Inc. |
brain segmentation, automated segmentation |
| David Wright
| University of Plymouth |
Bayesian, MCMC, Dynamic Latent trait. |
| Yi_Gen WU
| Nanjing University of information science and technology |
new method |
| Ying Wu
| Evanston Northwestern Healthcare |
Quantitative analysis, MRI, brain, hippocampus |
| Teresa Wu
| Arizona State University |
PET, data mining, statistical analysis |
| Zheng Xia
| The Methodist Hospital |
systems biology |
| Mantao Xu
| University of Joensuu |
filter |
| JUN XU
| NANJING MEDICAL UNIVERSITY |
ADNI CHINA |
| Zhong Xue
| The Methodist Hospital Research Institute |
serial image, registration, segmentation, multi-scale modeling |
| Naoko Yamaji
| Micron Inc |
J-ADNI |
| Fumio Yamashita
| University of Tsukuba |
TBM |
| Pingkun Yan
| University of Central Florida |
image segmentation, image registraion |
| Zhitong Yang
| University of Maryland School of Medicine |
Olfactory, smell, biomarker |
| Jerome Yesavage
| Stanford University |
Receiver Operator Characterists (ROC) |
| WaiKuan YIP
| Deakin University |
Deformable Model Registration |
| Kisook Yoo
| Hoffmann-La Roche |
biomarker \Alzheimer's disease |
| BONGIN YOO
| Bristol-Myers Squibb |
Alzheimer's Disease |
| yinan yu
| Chalmers |
ADHD |
| Peng Yu
| Eli LIlly and Company |
Classification, Bayesian methods |
| Kai Yuan
| Xi'dian University,China |
fMRI,VBM,DTI,AD |
| yi yuanfei
| hippocampus shape analysis |
hippocampus shape analysis |
| Paul Yushkevich
| University of Pennsylvania |
hippocampus, shape, medial, thickness |
| Laszlo Zaborszky
| Rutgers University |
automated measurement of regional brain volumes, basal forebrain |
| Vitali Zagorodnov
| Nanyang Technological University |
skull stripping, nonuniformity correction, data mining, pattern recognition |
| Michael Zagorski
| Case Western Reserve University |
amyloid, NMR |
| Alen Zamanyan
| University of California, Los Angeles |
segmentation, ROI, surface |
| Rezi Zawadzki
| Elan Pharmaceuticals |
MRI |
| Scott Zeger
| Johns Hopkins |
Cognitive decline; clinical trial outcome; ADAS Cog; biomarker |
| Jamie Zeitzer
| Stanford University |
circadian, sleep, agitation |
| Guang Zeng
| Mayo Clinic |
ADNI |
| Hui Zhang
| University of Pennsylvania |
Tensor-based morphometry |
| Yinghua Zhang
| GSK |
AD |
| Haili Zhang
| Beijing Normal University |
MRI, spm |
| Shu Zhang
| Eisai Medican Research Inc. |
Biomarker, Clinical research |
| Qinying Zhao
| Pfizer |
biomarker, cognition, ADAS-COG, MMSE, PK, PD, Clinical endpoint |
| xiantong zhen
| lanzhou university |
3556597 |
| xiantong zhen
| lanzhou university |
35565977878728 |
| yao zhijun
| lan zhou university |
morphometry analysis, human frain function |
| Sheng zhou
| hust |
registration |
| Yongxia Zhou
| Columbia Univ. |
dementia, cortical thickness, fiber tracking, fMRI |
| maohu zhu
| Chinese Academy Of Science |
feature selection, svm, fMRI |
| Liansheng Zhu
| Elan |
statistics |
| Jin Zhu
| Eisai Medical Research |
disease progression |
| Hongtu Zhu
| University of North Carolina at Chapel Hill |
Statistical methods, imaging analysis |
| Wanlin Zhu
| Institute of automaion , Chinese academy of sciences |
cortical thickness |
| wanlin zhu
| NeuroPsychiatric Institute |
morphometry AD |
| Hao Zhu
| Food and Drug Administration |
Disease model |
| Danielle Zigon
| Purdue University |
Nuclear Structure and Interactions |
| Maria Zontak
| Weizmann Institute |
automatic detection of anolaous regions |
| Yuchuan Zou
| Beijing Anding Hospital |
MRI a-beta AD diagnosis |
